Marc Goodman
Stock Analyst at Leerink Partners
(4.87)
# 340
Out of 4,988 analysts
844
Total ratings
56.7%
Success rate
19.1%
Average return
Main Sectors:
Stocks Rated by Marc Goodman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EOLS Evolus | Maintained: Buy | n/a | $7.99 | - | 43 | Sep 17, 2026 | |
| NGEN NervGen Pharma | Initiated Coverage: Buy | $10 | $2.13 | +369.48% | 1 | Jul 13, 2026 | |
| RAPP Rapport Therapeutics | Initiated Coverage: Buy | $52 | $41.39 | +25.63% | 1 | Jun 24, 2026 | |
| STOK Stoke Therapeutics | Reiterated: Buy | n/a | $27.91 | - | 11 | Jun 2, 2026 | |
| SPTX Seaport Therapeutics | Initiated Coverage: Buy | $35 | $22.14 | +58.08% | 1 | May 27, 2026 | |
| ACIU AC Immune | Reiterated: Buy | n/a | $2.65 | - | 38 | Apr 7, 2026 | |
| ALKS Alkermes | Reiterated: Hold | n/a | $46.07 | - | 45 | Mar 31, 2026 | |
| SGP SpyGlass Pharma | Initiated Coverage: Buy | $42 | $28.60 | +46.85% | 1 | Mar 3, 2026 | |
| MANE Veradermics | Initiated Coverage: Buy | $75 | $102.42 | -26.77% | 1 | Mar 2, 2026 | |
| NMRA Neumora Therapeutics | Initiated Coverage: Buy | $8 | $0.7732 | +934.66% | 1 | Jan 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 → $15 | $12.02 | +24.79% | 26 | Dec 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $30 | $11.40 | +163.16% | 1 | Nov 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $2.68 | +86.57% | 1 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $85 | $169.21 | -49.77% | 13 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $9.91 | +404.54% | 13 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 → $30 | $27.54 | +8.93% | 46 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $20 | $32.63 | -38.71% | 34 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $211.97 | - | 52 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $216.01 | - | 58 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $215 | $243.59 | -11.74% | 54 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $56.76 | - | 31 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $34 | $42.57 | -20.13% | 1 | Oct 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $149.50 | - | 48 | Sep 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $3.18 | n/a | 4 | Sep 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $20.06 | n/a | 16 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $1.37 | n/a | 40 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $37.85 | n/a | 6 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $36 | $4.14 | n/a | 11 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $4.22 | n/a | 33 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $1 | $0.023 | n/a | 9 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $267.28 | n/a | 1 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $14.11 | n/a | 17 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $24 | $1.69 | n/a | 1 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $70 | $1.98 | n/a | 12 | Jul 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20 | $68.57 | n/a | 10 | Jul 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $5.68 | n/a | 2 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $54.47 | n/a | 1 | May 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $153.69 | n/a | 1 | May 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $44.79 | n/a | 1 | May 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $31 | $273.41 | n/a | 1 | Apr 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $513.26 | n/a | 2 | Mar 19, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $473 | $774.61 | n/a | 1 | Nov 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $72 → $57 | $63.60 | n/a | 17 | May 21, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $46 → $54 | $17.02 | n/a | 8 | Mar 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $27.46 | n/a | 15 | Jan 31, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $34 → $20 | $38.53 | n/a | 26 | Dec 18, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $67 | $144.91 | n/a | 16 | Oct 30, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $95 | $262.51 | n/a | 14 | Oct 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $110 → $98 | $13.54 | n/a | 8 | Oct 5, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $85 | $1,137.82 | n/a | 12 | Jul 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $28 → $12 | $18.08 | n/a | 8 | Nov 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $118 | $147.68 | n/a | 3 | Nov 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $8 | $4.17 | n/a | 3 | Jun 14, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $7.98 | n/a | 24 | Mar 21, 2016 |
Evolus
Sep 17, 2026
Maintained: Buy
Price Target: n/a
Current: $7.99
Upside: -
NervGen Pharma
Jul 13, 2026
Initiated Coverage: Buy
Price Target: $10
Current: $2.13
Upside: +369.48%
Rapport Therapeutics
Jun 24, 2026
Initiated Coverage: Buy
Price Target: $52
Current: $41.39
Upside: +25.63%
Stoke Therapeutics
Jun 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $27.91
Upside: -
Seaport Therapeutics
May 27, 2026
Initiated Coverage: Buy
Price Target: $35
Current: $22.14
Upside: +58.08%
AC Immune
Apr 7, 2026
Reiterated: Buy
Price Target: n/a
Current: $2.65
Upside: -
Alkermes
Mar 31, 2026
Reiterated: Hold
Price Target: n/a
Current: $46.07
Upside: -
SpyGlass Pharma
Mar 3, 2026
Initiated Coverage: Buy
Price Target: $42
Current: $28.60
Upside: +46.85%
Veradermics
Mar 2, 2026
Initiated Coverage: Buy
Price Target: $75
Current: $102.42
Upside: -26.77%
Neumora Therapeutics
Jan 11, 2026
Initiated Coverage: Buy
Price Target: $8
Current: $0.7732
Upside: +934.66%
Dec 25, 2025
Reiterated: Buy
Price Target: $50 → $15
Current: $12.02
Upside: +24.79%
Nov 21, 2025
Initiated Coverage: Buy
Price Target: $30
Current: $11.40
Upside: +163.16%
Nov 17, 2025
Initiated Coverage: Buy
Price Target: $5
Current: $2.68
Upside: +86.57%
Oct 15, 2025
Reiterated: Buy
Price Target: $85
Current: $169.21
Upside: -49.77%
Oct 9, 2025
Reiterated: Buy
Price Target: $50
Current: $9.91
Upside: +404.54%
Oct 7, 2025
Reiterated: Buy
Price Target: $32 → $30
Current: $27.54
Upside: +8.93%
Oct 7, 2025
Reiterated: Buy
Price Target: $10 → $20
Current: $32.63
Upside: -38.71%
Oct 7, 2025
Reiterated: Buy
Price Target: n/a
Current: $211.97
Upside: -
Oct 7, 2025
Reiterated: Buy
Price Target: n/a
Current: $216.01
Upside: -
Oct 7, 2025
Reiterated: Buy
Price Target: $215
Current: $243.59
Upside: -11.74%
Oct 7, 2025
Reiterated: Buy
Price Target: n/a
Current: $56.76
Upside: -
Oct 6, 2025
Initiated Coverage: Buy
Price Target: $34
Current: $42.57
Upside: -20.13%
Sep 23, 2025
Reiterated: Buy
Price Target: n/a
Current: $149.50
Upside: -
Sep 16, 2025
Reiterated: Buy
Price Target: $20
Current: $3.18
Upside: n/a
Aug 13, 2025
Reiterated: Buy
Price Target: $40
Current: $20.06
Upside: n/a
Aug 12, 2025
Reiterated: Buy
Price Target: $10
Current: $1.37
Upside: n/a
Aug 1, 2025
Reiterated: Buy
Price Target: $20
Current: $37.85
Upside: n/a
Aug 1, 2025
Reiterated: Buy
Price Target: $36
Current: $4.14
Upside: n/a
May 13, 2025
Reiterated: Hold
Price Target: n/a
Current: $4.22
Upside: n/a
Mar 26, 2025
Downgraded: Hold
Price Target: $1
Current: $0.023
Upside: n/a
Jan 13, 2025
Reiterated: Buy
Price Target: n/a
Current: $267.28
Upside: n/a
May 12, 2023
Reiterated: Buy
Price Target: $4
Current: $14.11
Upside: n/a
Jan 24, 2023
Initiated Coverage: Buy
Price Target: $24
Current: $1.69
Upside: n/a
Jul 11, 2022
Reiterated: Hold
Price Target: $70
Current: $1.98
Upside: n/a
Jul 11, 2022
Reiterated: Hold
Price Target: $20
Current: $68.57
Upside: n/a
Jun 27, 2022
Reiterated: Hold
Price Target: n/a
Current: $5.68
Upside: n/a
May 3, 2022
Reiterated: Buy
Price Target: n/a
Current: $54.47
Upside: n/a
May 13, 2021
Reiterated: Buy
Price Target: $25
Current: $153.69
Upside: n/a
May 4, 2021
Reiterated: Buy
Price Target: n/a
Current: $44.79
Upside: n/a
Apr 5, 2021
Reiterated: Buy
Price Target: $31
Current: $273.41
Upside: n/a
Mar 19, 2019
Downgraded: Hold
Price Target: n/a
Current: $513.26
Upside: n/a
Nov 12, 2018
Initiated Coverage: Buy
Price Target: $473
Current: $774.61
Upside: n/a
May 21, 2018
Downgraded: Hold
Price Target: $72 → $57
Current: $63.60
Upside: n/a
Mar 1, 2018
Reiterated: Buy
Price Target: $46 → $54
Current: $17.02
Upside: n/a
Jan 31, 2018
Reiterated: Buy
Price Target: $42
Current: $27.46
Upside: n/a
Dec 18, 2017
Reiterated: Hold
Price Target: $34 → $20
Current: $38.53
Upside: n/a
Oct 30, 2017
Reiterated: Buy
Price Target: $67
Current: $144.91
Upside: n/a
Oct 13, 2017
Reiterated: Hold
Price Target: $95
Current: $262.51
Upside: n/a
Oct 5, 2017
Reiterated: Buy
Price Target: $110 → $98
Current: $13.54
Upside: n/a
Jul 26, 2017
Reiterated: Hold
Price Target: $85
Current: $1,137.82
Upside: n/a
Nov 10, 2016
Reiterated: Sell
Price Target: $28 → $12
Current: $18.08
Upside: n/a
Nov 2, 2016
Reiterated: Buy
Price Target: $118
Current: $147.68
Upside: n/a
Jun 14, 2016
Reiterated: Sell
Price Target: $8
Current: $4.17
Upside: n/a
Mar 21, 2016
Rated: Buy
Price Target: n/a
Current: $7.98
Upside: n/a